Anixa Biosciences与Moffitt Cancer Center已完成卵巢癌CAR-T临床试验第四组患者的给药工作,研究显示多名患者的生存期已超越预期的中位生存时间。
Anixa Biosciences与Moffitt Cancer Center已完成卵巢癌CAR-T临床试验第四组患者的给药工作,研究显示多名患者的生存期已超越预期的中位生存时间。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.